Drug
GSK2585823 clinical trials
Also written GSK2585823.
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses GSK2585823 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese SubjectsCompletedPhase 3GlaxoSmithKlineNCT01445301Written as GSK2585823(CLDM 1%-BPO 3% gel)
- Japanese Phase 1 Study of GSK2585823CompletedPhase 1GlaxoSmithKlineNCT01428466Written as GSK2585823
- A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne VulgarisCompletedPhase 1GlaxoSmithKlineNCT01527123Written as GSK2585823